Follow us on Twitter
twitter icon@FreshPatents


Bronchopulmonary patents

      

This page is updated frequently with new Bronchopulmonary-related patent applications.




 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof patent thumbnailCompositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
Such compositions can also further comprise various components such as lipids (for example fatty acids, esters thereof or derivatives thereof). Such compositions can be used for example in methods for treating an inflammatory diseases chosen from inflammatory bowel diseases, asthma, acute respiratory distress syndrome, chronic obstructive pulmonary disease, acute lung injury, bronchopulmonary dysplasia, cystic fibrosis, bronchitis, bronchiolitis, arthritis, osteoarthritis, ankylosing spondylitis and rheumatism..

 Monoterpenes for treating respiratory disorders, in particular bronchopulmonary disorders patent thumbnailMonoterpenes for treating respiratory disorders, in particular bronchopulmonary disorders
The invention relates to the combined use of at least one monoterpene which can be applied systemically, in particular perorally, and at least one respiratory tract therapeutic agent which can be applied topically, in particular through inhalation, for the prophylactic and/or therapeutic treatment, in particular combination therapy and/or co-medication, of respiratory tract diseases, in particular bronchopulmonary diseases. Through the combined use of the systemic monoterpene with the topical, in particular inhaled respiratory tract therapeutic agent, the effect or efficiency of the topical or inhaled respiratory disease therapeutic agent can be increased significantly, in particular in a synergistic manner, on the one hand, and the required dosage thereof can be reduced significantly on the other hand, combined with the resulting advantages (e.g., avoidance or reduction of side effects)..
Maria Clementine Martin Klosterfrau Vertriebsgesel Lschaft Mbh


 Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs patent thumbnailTreatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
Embodiments of the present invention provide a method for treatment of respiratory disorders such as asthma, chronic obstructive pulmonary disease, and chronic sinusitis, including cystic fibrosis, interstitial fibrosis, chronic bronchitis, emphysema, bronchopulmonary dysplasia and neoplasia. The method involves administration, preferably oral, nasal or pulmonary administration, of anti-inflammatory and anti-proliferative drugs (rapamycin or paclitaxel and their analogues) and an additive..
Lutonix, Inc.


 Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs patent thumbnailTreatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
Embodiments of the present invention provide a method for treatment of respiratory disorders such as asthma, chronic obstructive pulmonary disease, and chronic sinusitis, including cystic fibrosis, interstitial fibrosis, chronic bronchitis, emphysema, bronchopulmonary dysplasia and neoplasia. The method involves administration, preferably oral, nasal or pulmonary administration, of anti-inflammatory and anti-proliferative drugs (rapamycin or paclitaxel and their analogues)..
Lutonix, Inc.


 Methods and compositions for the reduction of neutrophil influx and the treatment of bronchopulmonary displasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease patent thumbnailMethods and compositions for the reduction of neutrophil influx and the treatment of bronchopulmonary displasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
The present invention relates generally to the use of recombinant human cc10 (rhcc10), also known as recombinant human uteroglobin, for use as a therapeutic in the treatment of respiratory distress syndrome (rds), bronchopulmonary dysplasia (bpd), chronic lung disease and/or pulmonary fibrosis, asthma and chronic obstructive pulmonary disease (copd). More particularly, the invention provides methods, including broadly the critical dosage ranges of rhcc10, which may be administered to safely and effectively treat the aforementioned conditions.
Therabron Therapeutics, Inc.


 Transdermal administration system for use in the treatment of chronic bronchopulmonary diseases patent thumbnailTransdermal administration system for use in the treatment of chronic bronchopulmonary diseases
Transdermal administration system comprising doxofylline as the active ingredient, for use in the treatment of bronchopulmonary diseases having a broncho-obstructive component.. .

 Compositions and methods of inhibiting gene expression in a lung patent thumbnailCompositions and methods of inhibiting gene expression in a lung
The present invention provides compositions and methods for delivery to a lung tissue comprising a small interfering rna (sirna) capable of inhibiting expression of a gene, and a surfactant. In one aspect, a non-polymeric methods composition comprising a small interfering rna (sirna) capable of inhibiting expression of a gene, and a surfactant is disclosed.
Yale University


 Surfactant protein d for the treatment of disorders associated with lung injury patent thumbnailSurfactant protein d for the treatment of disorders associated with lung injury
Surfactant protein d (sp-d) is a 43-kda member of the collectin family of collagenous lectin domain-containing proteins that is expressed in epithelial cells of the lung. Described herein are methods and compositions for the treatment of disorders associated with lung injury, including methods and compositions for the treatment of bronchopulmonary disorder (bpd) using recombinant human surfactant protein d and surfactant formulations..
Children's Hospital Medical Center


 Methods for treating inflammatory diseases with compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof patent thumbnailMethods for treating inflammatory diseases with compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof
There are provided methods for treating an inflammatory diseases chosen from inflammatory bowel diseases, asthma, acute respiratory distress syndrome, chronic obstructive pulmonary disease, acute lung injury, bronchopulmonary dysplasia, cystic fibrosis, bronchitis, bronchiolitis, arthritis, osteoarthritis, ankylosing spondylitis and rheumatism. The method comprise administering to a subject in need thereof an effective amount of at least one lipid and an effective amount of at least one compound chosen from compounds of the present disclosure.
Scf Pharma Inc.


 Combined therapeutic agent patent thumbnailCombined therapeutic agent
The invention relates to a combined therapeutic agent, preferably for use at the prophylactic and/or therapeutic treatment of (a) in particular inflammatory diseases of the respiratory tract, in particular bronchopulmonary diseases, or of (b) in particular inflammatory diseases of the gastrointestinal tract, in particular of the intestine. The combined therapeutic agent comprises at least one vitamin d receptor agonist (vda) and at least one further active substance, provided that the combined therapeutic agent does not contain any constituent and/or active substance from the group consisting of terpenes, monoterpenes, vasoconstrictors, alpha sympathomimetics and/or the physiologically harmless salts or derivatives thereof..

Use of tgf-beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia

The disclosure relates to methods of treating an infant at risk of developing bronchopulmonary dysplasia, including premature infants, by administering a tgf-β antagonist during the perinatal period, including the prenatal period and/or the postnatal period. For administration during the prenatal period, the tgf-β antagonist can be administered either directly to the infant in utero, or indirectly by administration to the mother..

Surfactant protein d for the treatment of disorders associated with lung injury

Surfactant protein d (sp-d) is a member of the collectin family of collagenous lectin domain-containing proteins that is expressed in epithelial cells of the lung. Described herein are methods and compositions for the treatment of disorders associated with lung injury, including methods and compositions for the treatment of bronchopulmonary disorder (bpd)..

Detecting, preventing, and treating bronchopulmonary dysplasia

Provided herein are methods for preventing or treating bronchopulmonary dysplasia (bpd) in a subject. The methods comprise identifying connective tissue mast cells (ctmcs) in a subject and administering an agent that blocks an activity of blocks an increase in a level of or reduces a level of the ctmcs in the subject.

Solid ambroxol-containing preparation

The present invention relates to solid preparations containing ambroxol which are obtainable by melt extrusion of the mixture consisting of a) 30 to 80% by weight of ambroxol hydrochloride, b) 2 to 68% by weight of at least one hydrogenated vegetable oil, c) 2 to 68% by weight of at least one mixture containing fatty acid ester and/or hydroxy fatty acid ester and d) 0 to 66% by weight of one or more pharmaceutical adjuvants, based in each case on the total amount of the preparation and its use for secretolytic treatment in acute and chronic bronchopulmonary diseases.. .



Bronchopulmonary topics:
  • Bronchopulmonary
  • Bronchopulmonary Dysplasia
  • Paclitaxel
  • Respiratory
  • Chronic Obstructive Pulmonary Disease
  • Recombinant
  • Aspergillosis
  • Multiple Sclerosis
  • Dermatitis
  • Proliferative
  • Chronic Sinusitis
  • Chronic Bronchitis
  • Cystic Fibrosis
  • Interstitial
  • Bronchitis


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Bronchopulmonary for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Bronchopulmonary with additional patents listed. Browse our RSS directory or Search for other possible listings.


    7.6608

    file didn't exist1387

    479197 - 0 - 25